EFTA00621382.pdf

Report Status: Final li bj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR624132A Client #: 78300020 56W5265 EPSTEIN, JEFFREY Requisition: 0002759 MOSKOWITZ,BRUCE W DOB: 01/20/1953 AGE: 64 BRUCE MOSKOWITZ,MD Gender: M Attn: NATIONWIDE ACCOUNT Collected: 08/09/2017 Phone: 561.366.0084 1411 N FLAGLER DR STE 7100 Received: 08/14/2017 108:51 EDT Patient ID: 19530120MJE WEST PALM BEACH,FL 33401-3418 Reported: 08/14/2017 108:51 EDT Health ID: 8573003290851249 Teat Name In Range Out Of Range Reference Range Lab LIPID PANEL CHOLESTEROL, TOTAL 211 H 125-200 mg/dL MI HDL CHOLESTEROL 25 L > OR = 40 mg/dL MI TRIGLYCERIDES 532 H <150 mg/dL MI LDL-CHOLESTEROL <130 mg/dL (talc) MI LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 8.4 H < OR = 5.0 (talc) MI NON HDL CHOLESTEROL 186 H mg/dL (talc) MI Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.8 mg/L TP Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 Years: hs-CRP mg/L Risk According to AHA/CDC Guidelines <1.0 Lower relative cardiovascular risk. 1.0-3.0 Average relative cardiovascular risk. 3.1-10.0 Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0 Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE 15.4 B <11.4 umol/L MI Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 94 65-99 mg/dL Fasting reference interval UREA NITROGEN (BUN) 19 7-25 mg/dL CREATININE 1.06 0.70-1.25 mg/dL For patients >49 years of age, the reference limit CLIENT SERVICES:866.697.8378 SPECIMEN: MR624132A PAGE I OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621382  Report Status: Final Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR624132A Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/09/2017 MOSKOWITZ. BRUCE W DOB: 01/20/1953 AGE: 64 Received: 08/14/2017 /08:51 EDT Gender: M Reported: 08/14/2017 / 08:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 74 > OR = 60 mL/min/1.73m2 eGFR AFRICAN AMERICAN 86 > OR = 60 mL/min/1.73m2 BUN/CREATININE RATIO NOT APPLICABLE 6-22 (calc) SODIUM 138 135-146 mmol/L POTASSIUM 4.3 3.5-5.3 mmol/L CHLORIDE 107 98-110 mmol/L CARBON DIOXIDE 23 20-31 mmol/L CALCIUM 9.5 8.6-10.3 mg/dL PROTEIN, TOTAL 6.7 6.1-8.1 g/dL ALBUMIN 4.2 3.6-5.1 g/dL GLOBULIN 2.5 1.9-3.7 g/dL (calc) ALBUMIN/GLOBULIN RATIO 1.7 1.0-2.5 (calc) BILIRUBIN, TOTAL 0.8 0.2-1.2 mg/dL ALKALINE PHOSPHATASE 57 40-115 U/L AST 22 10-35 U/L ALT 33 9-46 U/L HEMOGLOBIN Ale 5.7 B <5.7 % of total Hgb MI For someone without known diabetes, a hemoglobin Ale value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Ale targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Ale for diagnosis of diabetes for children. URIC ACID 6.9 4.0-8.0 mg/dL MI Therapeutic target for gout patients: <6.0 mg/dL TSH 4.17 0.40-4.50 mIU/L MI T4 (THYROXINE), TOTAL 7.1 4.5-12.0 mcg/dL MI FREE T4 INDEX (T7) 2.1 1.4-3.8 T3 UPTAKE 30 22-35 % MI SED RATE BY MODIFIED MI WESTERGREN 9 < OR = 20 mm/h CBC (INCLUDES DIFF/PLT) MI WHITE BLOOD CELL COUNT 6.0 3.8-10.8 Thousand/uL RED BLOOD CELL COUNT 5.37 4.20-5.80 Million/uL HEMOGLOBIN 15.0 13.2-17.1 g/dL HEMATOCRIT 45.2 38.5-50.0 % MCV 84.2 80.0-100.0 fL MCH 27.9 27.0-33.0 pg MCHC 33.2 32.0-36.0 g/dL RDW 14.3 11.0-15.0 % PLATELET COUNT 281 140-400 Thousand/uL CLIENT SERVICES:866.697.8378 SPECIMEN: MR624132A PAGE 2OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621383  Report Status: Final a b) Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR624132A Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/09/2017 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 64 Received: 08/14/2017 108:51 EDT Gender: M Reported: 08/14/2017 108:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab MPV 9.7 7.5-12.5 fL ABSOLUTE NEUTROPHILS 2664 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2304 850-3900 cells/uL ABSOLUTE MONOCYTES 510 200-950 cells/uL ABSOLUTE EOSINOPHILS 450 15-500 cells/uL ABSOLUTE BASOPHILS 72 0-200 cells/uL NEUTROPHILS 44.4 LYMPHOCYTES 38.4 MONOCYTES 8.5 EOSINOPHILS 7.5 BASOPHILS 1.2 URINALYSIS, COMPLETE MI See Endnote 2 VITAMIN B12 439 200-1100 pg/mL MI C-REACTIVE PROTEIN 0.12 <0.80 mg/dL MI Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. CORTISOL, TOTAL 20 2 mcg/dL MI Reference Range: For 8 .(7-9 .) Specimen: 4.0-22.0 Reference Range: For 4 .(3-5 .) Specimen: 3.0-17.0 * Please interpret above results accordingly * TESTOSTERONE, TOTAL MI MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 197 L 250-827 ng/dL Men with clinically significant hypogonadal symptoms and testosterone values repeatedly less than approximately 300 ng/dL may benefit from testosterone treatment after adequate risk and benefits counseling. In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a red-top tube with no gel. Two morning (8-10 III.) specimens obtained on different days are recommended by The Endocrine Society for screening for hypogonadism. PSA, TOTAL 0.5 < OR = 4.0 ng/mL MI The total PSA value from this assay system is standardized against the WHO standard. The test result will be approximately 20% lower when compared to the equimolar-standardized total PSA (Beckman Coulter). Comparison of serial PSA results should be interpreted with this fact in mind. This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. Endnote I 1*** ******************* **Irtt**Ortt** * Test not performed. CLIENT SERVICES: 866.697.8378 SPECIMEN: MR624132A PAGE30F5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621384  Report Status: Final raj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR624132A Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/09/2017 MOSKOWITZ. BRUCE W DOB: 01/20/1953 AGE: 64 Received: 08/14/2017 / 08:51 EDT Gender: M Reported: 08/14/2017 108:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 * No urine received. * CLIENT SERVICES: 866.697.8378 SPECIMEN: MR624132A PAGE 4 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621385  Report Status: Final raj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR624132A Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/09/2017 MOSKOWITZ. BRUCE W DOB: 01/20/1953 AGE: 64 Received: 08/14/2017 /08:51 EDT Gender: M Reported: 08/14/2017 / 08:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Endocrinology Test Name Result Reference Range Lab VITAMIN D,25.OH,TOTAL,IA 35 30-100 ng/mL MI Vitamin D Status 25-OH Vitamin D: Deficiency: <20 ng/mL Insufficiency: 20 - 29 ng/mL Optimal: > or = 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: (This link is being provided for informational/educational purposes only.) Physician Comments: PERFORMING SITE: MI QUEST DIAGNOSTICS.MIAMI. I020000MMERCE PARKWAY. MIRAMAR. FL 330254938 Laboratory GLEN L. NORM MD FIR/ CI.IA: 1000277334 TP QUEST DIAGNOSTICS.TAMPA. 4225 E FOWLER AVE TAMPA. FL 33617.2026 Laboratory Duo:tor GLEN L IIORTIN.MD.PIID. CLIA 1000291120 CLIENTSERVICES:866.6971378 SPECIMEN: MR624132A PAGE 5 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00621386